The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Ischemic Stroke Drugs Market Research Report 2025

Global Ischemic Stroke Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713823

No of Pages : 89

Ask Your Query

Synopsis

Market Analysis and Insights: Global Ischemic Stroke Drugs Market

Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.

The global Ischemic Stroke Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ischemic Stroke Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ischemic Stroke Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ischemic Stroke Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ischemic Stroke Drugs market.

Global Ischemic Stroke Drugs Scope and Market Size
Ischemic Stroke Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Ischemic Stroke Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Antihypertensive
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Pfizer
  • Merck
  • Boehringer Ingelheim
  • Sanofi
  • Johnson & Johnson
  • Bayer
  • Biogen
  • Abbott Laboratories
  • Genentech
  • Daiichi Sankyo
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemic Stroke Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tissue Plasminogen Activator
1.2.3 Anticoagulant
1.2.4 Antiplatelet
1.2.5 Antihypertensive
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ischemic Stroke Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ischemic Stroke Drugs Market Perspective (2017-2028)
2.2 Ischemic Stroke Drugs Growth Trends by Region
2.2.1 Ischemic Stroke Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ischemic Stroke Drugs Historic Market Size by Region (2017-2022)
2.2.3 Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028)
2.3 Ischemic Stroke Drugs Market Dynamics
2.3.1 Ischemic Stroke Drugs Industry Trends
2.3.2 Ischemic Stroke Drugs Market Drivers
2.3.3 Ischemic Stroke Drugs Market Challenges
2.3.4 Ischemic Stroke Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ischemic Stroke Drugs Players by Revenue
3.1.1 Global Top Ischemic Stroke Drugs Players by Revenue (2017-2022)
3.1.2 Global Ischemic Stroke Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ischemic Stroke Drugs Revenue
3.4 Global Ischemic Stroke Drugs Market Concentration Ratio
3.4.1 Global Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemic Stroke Drugs Revenue in 2021
3.5 Ischemic Stroke Drugs Key Players Head office and Area Served
3.6 Key Players Ischemic Stroke Drugs Product Solution and Service
3.7 Date of Enter into Ischemic Stroke Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemic Stroke Drugs Breakdown Data by Type
4.1 Global Ischemic Stroke Drugs Historic Market Size by Type (2017-2022)
4.2 Global Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028)
5 Ischemic Stroke Drugs Breakdown Data by Application
5.1 Global Ischemic Stroke Drugs Historic Market Size by Application (2017-2022)
5.2 Global Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Ischemic Stroke Drugs Market Size (2017-2028)
6.2 North America Ischemic Stroke Drugs Market Size by Country (2017-2022)
6.3 North America Ischemic Stroke Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Ischemic Stroke Drugs Market Size (2017-2028)
7.2 Europe Ischemic Stroke Drugs Market Size by Country (2017-2022)
7.3 Europe Ischemic Stroke Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ischemic Stroke Drugs Market Size (2017-2028)
8.2 Asia-Pacific Ischemic Stroke Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Ischemic Stroke Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Ischemic Stroke Drugs Market Size (2017-2028)
9.2 Latin America Ischemic Stroke Drugs Market Size by Country (2017-2022)
9.3 Latin America Ischemic Stroke Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ischemic Stroke Drugs Market Size (2017-2028)
10.2 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ischemic Stroke Drugs Introduction
11.1.4 Pfizer Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Ischemic Stroke Drugs Introduction
11.2.4 Merck Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Ischemic Stroke Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Ischemic Stroke Drugs Introduction
11.4.4 Sanofi Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Ischemic Stroke Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Ischemic Stroke Drugs Introduction
11.6.4 Bayer Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.6.5 Bayer Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Ischemic Stroke Drugs Introduction
11.7.4 Biogen Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.7.5 Biogen Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Ischemic Stroke Drugs Introduction
11.8.4 Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.8.5 Abbott Laboratories Recent Development
11.9 Genentech
11.9.1 Genentech Company Detail
11.9.2 Genentech Business Overview
11.9.3 Genentech Ischemic Stroke Drugs Introduction
11.9.4 Genentech Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.9.5 Genentech Recent Development
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Detail
11.10.2 Daiichi Sankyo Business Overview
11.10.3 Daiichi Sankyo Ischemic Stroke Drugs Introduction
11.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2017-2022)
11.10.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tissue Plasminogen Activator
Table 3. Key Players of Anticoagulant
Table 4. Key Players of Antiplatelet
Table 5. Key Players of Antihypertensive
Table 6. Key Players of Others
Table 7. Global Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Ischemic Stroke Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Ischemic Stroke Drugs Market Share by Region (2017-2022)
Table 11. Global Ischemic Stroke Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Ischemic Stroke Drugs Market Share by Region (2023-2028)
Table 13. Ischemic Stroke Drugs Market Trends
Table 14. Ischemic Stroke Drugs Market Drivers
Table 15. Ischemic Stroke Drugs Market Challenges
Table 16. Ischemic Stroke Drugs Market Restraints
Table 17. Global Ischemic Stroke Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Ischemic Stroke Drugs Market Share by Players (2017-2022)
Table 19. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemic Stroke Drugs as of 2021)
Table 20. Ranking of Global Top Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ischemic Stroke Drugs Product Solution and Service
Table 24. Date of Enter into Ischemic Stroke Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ischemic Stroke Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Ischemic Stroke Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Ischemic Stroke Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Ischemic Stroke Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Ischemic Stroke Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Ischemic Stroke Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Ischemic Stroke Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Ischemic Stroke Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Ischemic Stroke Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Ischemic Stroke Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Pfizer Company Detail
Table 45. Pfizer Business Overview
Table 46. Pfizer Ischemic Stroke Drugs Product
Table 47. Pfizer Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 48. Pfizer Recent Development
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Ischemic Stroke Drugs Product
Table 52. Merck Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Boehringer Ingelheim Company Detail
Table 55. Boehringer Ingelheim Business Overview
Table 56. Boehringer Ingelheim Ischemic Stroke Drugs Product
Table 57. Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 58. Boehringer Ingelheim Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Ischemic Stroke Drugs Product
Table 62. Sanofi Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Johnson & Johnson Company Detail
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Ischemic Stroke Drugs Product
Table 67. Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Bayer Company Detail
Table 70. Bayer Business Overview
Table 71. Bayer Ischemic Stroke Drugs Product
Table 72. Bayer Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Biogen Company Detail
Table 75. Biogen Business Overview
Table 76. Biogen Ischemic Stroke Drugs Product
Table 77. Biogen Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 78. Biogen Recent Development
Table 79. Abbott Laboratories Company Detail
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Ischemic Stroke Drugs Product
Table 82. Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 83. Abbott Laboratories Recent Development
Table 84. Genentech Company Detail
Table 85. Genentech Business Overview
Table 86. Genentech Ischemic Stroke Drugs Product
Table 87. Genentech Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 88. Genentech Recent Development
Table 89. Daiichi Sankyo Company Detail
Table 90. Daiichi Sankyo Business Overview
Table 91. Daiichi Sankyo Ischemic Stroke Drugs Product
Table 92. Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2017-2022) & (US$ Million)
Table 93. Daiichi Sankyo Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemic Stroke Drugs Market Share by Type: 2021 VS 2028
Figure 2. Tissue Plasminogen Activator Features
Figure 3. Anticoagulant Features
Figure 4. Antiplatelet Features
Figure 5. Antihypertensive Features
Figure 6. Others Features
Figure 7. Global Ischemic Stroke Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Ischemic Stroke Drugs Report Years Considered
Figure 13. Global Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Ischemic Stroke Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Ischemic Stroke Drugs Market Share by Region: 2021 VS 2028
Figure 16. Global Ischemic Stroke Drugs Market Share by Players in 2021
Figure 17. Global Top Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemic Stroke Drugs as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Ischemic Stroke Drugs Revenue in 2021
Figure 19. North America Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Ischemic Stroke Drugs Market Share by Country (2017-2028)
Figure 21. United States Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Ischemic Stroke Drugs Market Share by Country (2017-2028)
Figure 25. Germany Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Ischemic Stroke Drugs Market Share by Region (2017-2028)
Figure 33. China Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Ischemic Stroke Drugs Market Share by Country (2017-2028)
Figure 41. Mexico Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Ischemic Stroke Drugs Market Share by Country (2017-2028)
Figure 45. Turkey Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Ischemic Stroke Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 48. Merck Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 50. Sanofi Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 51. Johnson & Johnson Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 52. Bayer Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 53. Biogen Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 54. Abbott Laboratories Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 55. Genentech Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 56. Daiichi Sankyo Revenue Growth Rate in Ischemic Stroke Drugs Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock